Abdominal aortic aneurysm screening: Difference between revisions
Jump to navigation
Jump to search
(/* Screening High-Risk Populations (DO NOT EDIT){{cite journal |author=Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, Whit...) |
No edit summary |
||
| (18 intermediate revisions by 9 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{| class="infobox" style="float:right;" | |||
|- | |||
| [[File:Siren.gif|30px|link=Abdominal aortic aneurysm screening and prevention resident survival guide]]|| <br> || <br> | |||
| [[Abdominal aortic aneurysm screening and prevention resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | |||
|} | |||
{{Template:Abdominal aortic aneurysm}} | {{Template:Abdominal aortic aneurysm}} | ||
{{CMG}}; | {{CMG}}; {{AE}} Caitlin J. Harrigan [mailto:charrigan@perfuse.org]; {{VVS}} {{RG}} | ||
==Overview== | |||
Approximately 16% of large abdominal aortic aneurysms (diameter > 5.5 cm) rupture, causing 9,000 AAA-related deaths in the United States per year. Several studies have shown that screening can drastically reduce the aneurysm rupture rate by 45-49% for men older than 60, and reduce AAA-related mortality by 21-68%. In a landmark study randomizing 67,800 men, (The Multicenter Aneurysm Screening Study) aneurysm-related mortality was 53% lower in the screening group as compared with control patients. The United States Preventive Services Task Force ([[USPSTF]]) recommends one-time screening for abdominal aortic aneurysm (AAA) by [[ultrasonography]] in any man, aged 65 to 75 who has ever smoked. The [[USPSTF]] makes no recommendation for or against screening for AAA in men aged 65 to 75 who have never smoked. The [[USPSTF]] recommends against routine screening for AAA in women. | |||
==Screening== | |||
* Patients with [[Abdominal Aortic Aneurysm|abdominal aortic aneurysms]] (AAAs) are often [[asymptomatic]], with the first clinical event often being [[fatal]] or life-threatening.<ref name="pmid7490591">{{cite journal | author = Gillum RF | title = Epidemiology of aortic aneurysm in the United States | journal = [[Journal of Clinical Epidemiology]] | volume = 48 | issue = 11 | pages = 1289–98 | year = 1995 | month = November | pmid = 7490591 | doi = | url = http://linkinghub.elsevier.com/retrieve/pii/0895-4356(95)00045-3 | issn = | accessdate = 2012-10-27}}</ref> | |||
* Due to this apparent "detection gap," between the asymptomatic disease and clinically apparent disease [[Screening (medicine)|screening]] may be of benefit.<ref name="pmid12433761">{{cite journal | author = | title = Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial | journal = [[BMJ (Clinical Research Ed.)]] | volume = 325 | issue = 7373 | pages = 1135 | year = 2002 | month = November | pmid = 12433761 | pmc = 133450 | doi = | url = http://www.bmj.com/cgi/pmidlookup?view=long&pmid=12433761 | issn = | accessdate = 2012-10-27}}</ref> | |||
* AAAs are usually [[asymptomatic]] during this "detection gap", with the possibility of as many as one in three [[Rupture of a vascular malformation|rupturing]] if left untreated.<ref name="pmid12443589">{{cite journal | author = Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, Thompson SG, Walker NM | title = The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial | journal = [[Lancet]] | volume = 360 | issue = 9345 | pages = 1531–9 | year = 2002 | month = November | pmid = 12443589 | doi = | url = http://linkinghub.elsevier.com/retrieve/pii/S0140673602115224 | issn = | accessdate = 2012-10-27}}</ref> | |||
* A ruptured AAA carries an overall [[Mortality rate|mortality]] rate approaching 75%, with a mortality rate of 2-6% in those patients who underwent [[Elective surgery|elective surgical]] repair.<ref name="pmid12798553">{{cite journal | author = Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PW, Houston-Miller N | title = 34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap? | journal = [[Journal of the American College of Cardiology]] | volume = 41 | issue = 11 | pages = 1863–74 | year = 2003 | month = June | pmid = 12798553 | doi = | url = http://linkinghub.elsevier.com/retrieve/pii/S0735109703003589 | issn = | accessdate = 2012-10-27}}</ref> | |||
* Approximately 16% of large AAAs (diameter >5.5 cm) rupture, causing 9,000 AAA-related deaths in the United States per year. | |||
* Several studies have shown that screening can drastically reduce the aneurysm rupture rate by 45-49% for men older than 60, and reduce AAA-related [[Mortality rate|mortality]] by 21-68%. | |||
== | ===Landmark Trial in AAA Screening === | ||
* In the largest population-based screening study to date, the Multi center Aneurysm Screening Study (MASS) randomized 67,800 men (age 65-74) equally to either a group that received an [[ultrasound]] screening for AAA or a control group. <ref name="pmid12443589">{{cite journal | author = Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, Thompson SG, Walker NM | title = The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial | journal = [[Lancet]] | volume = 360 | issue = 9345 | pages = 1531–9 | year = 2002 | month = November | pmid = 12443589 | doi = | url = http://linkinghub.elsevier.com/retrieve/pii/S0140673602115224 | issn = | accessdate = 2012-10-27}}</ref><ref name="pmid12433761">{{cite journal | author = | title = Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial | journal = [[BMJ (Clinical Research Ed.)]] | volume = 325 | issue = 7373 | pages = 1135 | year = 2002 | month = November | pmid = 12433761 | pmc = 133450 | doi = | url = http://www.bmj.com/cgi/pmidlookup?view=long&pmid=12433761 | issn = | accessdate = 2012-10-27}}</ref> | |||
* In the largest population-based screening study to date, the | |||
* In the screening group, men with an abdominal aorta larger than 3 cm in diameter were followed with serial ultrasounds for a mean duration of 4.1 years. | * In the screening group, men with an abdominal aorta larger than 3 cm in diameter were followed with serial ultrasounds for a mean duration of 4.1 years. | ||
* When the aneurysm reached 5.5 cm, grew more than 1 cm/year or became symptomatic, it was repaired surgically. | * When the aneurysm reached 5.5 cm, grew more than 1 cm/year or became symptomatic, it was repaired surgically. | ||
| Line 20: | Line 27: | ||
* However, despite the relative risk reduction in the MASS trial, there were 65 AAA-related deaths in the intervention group (absolute risk of 0.19%), and 113 AAA-related deaths in the control group (absolute risk 0.33%). | * However, despite the relative risk reduction in the MASS trial, there were 65 AAA-related deaths in the intervention group (absolute risk of 0.19%), and 113 AAA-related deaths in the control group (absolute risk 0.33%). | ||
== Cost-Effectiveness | ===Screening=== | ||
It is estimated that abdominal aortic aneurysm screening is as cost-effective as mammography for breast cancer detection as well as therapeutic interventions such as coronary artery bypass graft surgery with a cost of $11,285 per quality adjusted life year saved.<ref name="pmid14718853">{{cite journal | author = Kent KC, Zwolak RM, Jaff MR, Hollenbeck ST, Thompson RW, Schermerhorn ML, Sicard GA, Riles TS, Cronenwett JL | title = Screening for abdominal aortic aneurysm: a consensus statement | journal = [[Journal of Vascular Surgery]] | volume = 39 | issue = 1 | pages = 267–9 | year = 2004 | month = January | pmid = 14718853 | doi = 10.1016/j.jvs.2003.08.019 | url = http://linkinghub.elsevier.com/retrieve/pii/S0741521403012230 | issn = | accessdate = 2012-10-27}}</ref> | |||
====Cost-Effectiveness==== | |||
It is estimated that abdominal aortic aneurysm screening is as cost-effective as mammography for breast cancer detection as well as therapeutic interventions such as [[coronary artery bypass graft surgery]] with a cost of $11,285 per quality adjusted life year saved.<ref name="pmid14718853">{{cite journal | author = Kent KC, Zwolak RM, Jaff MR, Hollenbeck ST, Thompson RW, Schermerhorn ML, Sicard GA, Riles TS, Cronenwett JL | title = Screening for abdominal aortic aneurysm: a consensus statement | journal = [[Journal of Vascular Surgery]] | volume = 39 | issue = 1 | pages = 267–9 | year = 2004 | month = January | pmid = 14718853 | doi = 10.1016/j.jvs.2003.08.019 | url = http://linkinghub.elsevier.com/retrieve/pii/S0741521403012230 | issn = | accessdate = 2012-10-27}}</ref> | |||
====Safety==== | |||
* Physical examinations may detect large AAAs, but is not specific or sensitive enough to detect smaller ones.<ref name="FinkLederle2000">{{cite journal|last1=Fink|first1=Howard A.|last2=Lederle|first2=Frank A.|last3=Roth|first3=Craig S.|last4=Bowles|first4=Carolyn A.|last5=Nelson|first5=David B.|last6=Haas|first6=Michele A.|title=The Accuracy of Physical Examination to Detect Abdominal Aortic Aneurysm|journal=Archives of Internal Medicine|volume=160|issue=6|year=2000|pages=833|issn=0003-9926|doi=10.1001/archinte.160.6.833}}</ref> | |||
* The cornerstone of AAA screening is [[ultrasonography]]. It is available in almost every medical center and many physician offices. | |||
* Abdominal aortic [[ultrasonography]] is fast, inexpensive, safe and well-tolerated by most patients | |||
* It is highly accurate with 95% sensitivity and 100% specificity for AAAs.<ref name="RubanoMehta2013">{{cite journal|last1=Rubano|first1=Elizabeth|last2=Mehta|first2=Ninfa|last3=Caputo|first3=William|last4=Paladino|first4=Lorenzo|last5=Sinert|first5=Richard|last6=Carpenter|first6=Christopher|title=Systematic Review: Emergency Department Bedside Ultrasonography for Diagnosing Suspected Abdominal Aortic Aneurysm|journal=Academic Emergency Medicine|volume=20|issue=2|year=2013|pages=128–138|issn=10696563|doi=10.1111/acem.12080}}</ref> | |||
* The most important limitations of [[ultrasonography]] are: | |||
:* Operator dependence | :* Operator dependence | ||
:* Reduced accuracy in those patients with bowel gas, periaortic disease and those patients who are obese | :* Reduced [[Accuracy and precision|accuracy]] in those patients with bowel gas, periaortic disease and those patients who are [[obese]]. | ||
:* These limitations present less of an issue for highly experienced sonographers, and in accredited, validated, high-volume institutions | :* These limitations present less of an issue for highly experienced sonographers, and in accredited, validated, high-volume institutions. | ||
* Computed tomography (CT) and magnetic resonance angiography are accurate for diagnosing AAA, but are less often used as a first-degree screening modality because of the lack of availability, and the risks and side-effects of iodinated contrasts for CT. | * Computed tomography ([[CT]]) and [[magnetic resonance angiography]] are accurate for diagnosing AAA, but are less often used as a first-degree screening modality because of the lack of availability, and the risks and side-effects of iodinated contrasts for [[CT]]. | ||
====Ethics==== | |||
* Screening using [[ultrasonography]] causes no serious side effects, and is therefore ethically acceptable.<ref name="Haar2011">{{cite journal|last1=Haar|first1=Gail ter|title=Ultrasonic imaging: safety considerations|journal=Interface Focus|volume=1|issue=4|year=2011|pages=686–697|issn=2042-8898|doi=10.1098/rsfs.2011.0029}}</ref> | |||
* Several studies have shown that screening for AAAs and diagnosing asymptomatic small aneurysms in clinical practice were not associated with long-term emotional or psychological stress to patients.<ref name="pmid11488791">{{cite journal | author = Vammen S, Lindholt JS, Ostergaard L, Fasting H, Henneberg EW | title = Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion | journal = [[The British Journal of Surgery]] | volume = 88 | issue = 8 | pages = 1066–72 | year = 2001 | month = August | pmid = 11488791 | doi = 10.1046/j.0007-1323.2001.01845.x | url = http://dx.doi.org/10.1046/j.0007-1323.2001.01845.x | issn = | accessdate = 2012-10-27}}</ref> | |||
* A simple screening ultrasound test costs approximately $500, for which Medicare usually reimburses $160. | |||
* Lack of insurance coverage raises the ethical dilemma of AAA screening being available only to the elite who can afford it. | |||
== | ====Identification as a Trigger to Screen for Polyvascular Disease==== | ||
* Small, asymptomatic AAAs (3-5.5 cm) may serve as a marker for vascular disease elsewhere, thus finding one provides good reason to aggressively start to modify risk factors. | * Small, asymptomatic AAAs (3-5.5 cm) may serve as a marker for vascular disease elsewhere, thus finding one provides good reason to aggressively start to modify risk factors. | ||
== | ===Follow-Up Intervals=== | ||
* Periodic ultrasonographic surveillance is recommended for aneurysms smaller than the repair cutoff | * Periodic [[Medical ultrasonography|ultrasonographic]] [[Survey sampling|surveillance]] is recommended for aneurysms smaller than the repair cutoff. | ||
* If an abdominal aortic aneurysm is 4 to 5.4 cm then surveillance ultrasounds can be obtained every 6 to 12 months | * If an abdominal aortic aneurysm is 4 to 5.4 cm then surveillance ultrasounds can be obtained every 6 to 12 months. | ||
* If an abdominal aortic aneurysm is 3 to 4 cm then surveillance ultrasounds can be obtained every 2 to 3 years | * If an abdominal aortic aneurysm is 3 to 4 cm then surveillance ultrasounds can be obtained every 2 to 3 years. | ||
* However, definite and unified parameters for appropriate surveillance intervals have not yet been determined because clinical trials have enrolled heterogeneous populations and used different standards for diagnosis and management | * However, definite and unified parameters for appropriate surveillance intervals have not yet been determined because clinical trials have enrolled heterogeneous populations and used different standards for diagnosis and management. | ||
* In general, older men may need more frequent follow-up scans, as men older than 70 years have three times the rate of progression than younger men | * In general, older men may need more frequent follow-up scans, as men older than 70 years have three times the rate of progression than younger men. | ||
* Aneurysm diameters determined by ultrasound may vary up to 0.5 cm, which should be considered when recommending | * Aneurysm diameters determined by ultrasound may vary up to 0.5 cm, which should be considered when recommending optimal times for rescanning and repair. | ||
===Recommendations by The United States Preventive Service Task Force=== | |||
[[Clinical practice guideline]]s<ref name="pmid24957320">{{cite journal| author=LeFevre ML| title=Screening for Abdominal Aortic Aneurysm: U.S. Preventive Services Task Force Recommendation Statement. | journal=Ann Intern Med | year= 2014 | volume= | issue= | pages= | pmid=24957320 | doi=10.7326/M14-1204 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24957320 }} </ref> and [[systematic review]]<ref name="pmid24473919">{{cite journal| author=Guirguis-Blake JM, Beil TL, Senger CA, Whitlock EP| title=Ultrasonography screening for abdominal aortic aneurysms: a systematic evidence review for the U.S. Preventive Services Task Force. | journal=Ann Intern Med | year= 2014 | volume= 160 | issue= 5 | pages= 321-9 | pmid=24473919 | doi=10.7326/M13-1844 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24473919 }} [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24842440 Review in: Ann Intern Med. 2014 May 20;160(10):JC6] </ref> by the [[USPSTF|United States Preventive Service Task Force]] in 2014 stated: | |||
* "The [[USPSTF]] recommends 1-time screening screening for AAA with [[ultrasonography]] in men aged 65 to 75 years who have ever smoked." | |||
* "The [[USPSTF]] recommends that clinicians selectively offer screening for AAA in men aged 65 to 75 years who have never smoked" | |||
* "The [[USPSTF]] concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for AAA in women aged 65 to 75 years who have ever smoked" | |||
* "The [[USPSTF]] recommends against routine screening for AAA in women who have never smoked." | |||
== | The projected benefit of screening is:<ref name="pmid24842440">{{cite journal| author=Burden AC| title=ACP Journal Club. Review: ultrasonography screening reduces long-term abdominal aortic aneurysm-related mortality. | journal=Ann Intern Med | year= 2014 | volume= 160 | issue= 10 | pages= JC6 | pmid=24842440 | doi=10.7326/0003-4819-160-10-201405200-02006 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24842440 }} </ref> | ||
* Number needed to invite to prevent one death is 175 - 225. | |||
* | |||
== | ==Management of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations) : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines== | ||
===Screening High-Risk Populations<ref name="pmid23473760">{{cite journal| author=Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss L et al.| title=Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. | journal=J Am Coll Cardiol | year= 2013 | volume= 61 | issue= 14 | pages= 1555-70 | pmid=23473760 | doi=10.1016/j.jacc.2013.01.004 | pmc=4492473 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23473760 }} </ref>=== | |||
{|class="wikitable" | {|class="wikitable" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA Guidelines Classification Scheme#Classification of Recommendations|Class I]] | | colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA Guidelines Classification Scheme#Classification of Recommendations|Class I]] | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Men 60 years of age or older who are either the siblings or offspring of patients with AAAs should undergo physical examination and | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.'''Men 60 years of age or older who are either the siblings or offspring of patients with AAAs should undergo physical examination and ultrasound screening for detection of aortic aneurysms. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
|} | |} | ||
{|class="wikitable" | {|class="wikitable" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA | | colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' Men who are 65 to 75 years of age who have ever smoked should undergo a physical examination and 1-time ultrasound screening for detection of AAAs. ''([[ACC AHA | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''Men who are 65 to 75 years of age who have ever smoked should undergo a physical examination and 1-time ultrasound screening for detection of AAAs. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
|} | |} | ||
| Line 80: | Line 96: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[CME Category::Cardiology]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
| Line 85: | Line 102: | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Up-To-Date cardiology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Best pages]] | |||
Latest revision as of 21:57, 6 January 2020
 |
Resident Survival Guide |
|
Abdominal Aortic Aneurysm Microchapters |
|
Differentiating Abdominal Aortic Aneurysm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Abdominal aortic aneurysm screening On the Web |
|
Directions to Hospitals Treating Abdominal aortic aneurysm screening |
|
Risk calculators and risk factors for Abdominal aortic aneurysm screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Caitlin J. Harrigan [2]; Vishnu Vardhan Serla M.B.B.S. [3] Ramyar Ghandriz MD[4]
Overview
Approximately 16% of large abdominal aortic aneurysms (diameter > 5.5 cm) rupture, causing 9,000 AAA-related deaths in the United States per year. Several studies have shown that screening can drastically reduce the aneurysm rupture rate by 45-49% for men older than 60, and reduce AAA-related mortality by 21-68%. In a landmark study randomizing 67,800 men, (The Multicenter Aneurysm Screening Study) aneurysm-related mortality was 53% lower in the screening group as compared with control patients. The United States Preventive Services Task Force (USPSTF) recommends one-time screening for abdominal aortic aneurysm (AAA) by ultrasonography in any man, aged 65 to 75 who has ever smoked. The USPSTF makes no recommendation for or against screening for AAA in men aged 65 to 75 who have never smoked. The USPSTF recommends against routine screening for AAA in women.
Screening
- Patients with abdominal aortic aneurysms (AAAs) are often asymptomatic, with the first clinical event often being fatal or life-threatening.[1]
- Due to this apparent "detection gap," between the asymptomatic disease and clinically apparent disease screening may be of benefit.[2]
- AAAs are usually asymptomatic during this "detection gap", with the possibility of as many as one in three rupturing if left untreated.[3]
- A ruptured AAA carries an overall mortality rate approaching 75%, with a mortality rate of 2-6% in those patients who underwent elective surgical repair.[4]
- Approximately 16% of large AAAs (diameter >5.5 cm) rupture, causing 9,000 AAA-related deaths in the United States per year.
- Several studies have shown that screening can drastically reduce the aneurysm rupture rate by 45-49% for men older than 60, and reduce AAA-related mortality by 21-68%.
Landmark Trial in AAA Screening
- In the largest population-based screening study to date, the Multi center Aneurysm Screening Study (MASS) randomized 67,800 men (age 65-74) equally to either a group that received an ultrasound screening for AAA or a control group. [3][2]
- In the screening group, men with an abdominal aorta larger than 3 cm in diameter were followed with serial ultrasounds for a mean duration of 4.1 years.
- When the aneurysm reached 5.5 cm, grew more than 1 cm/year or became symptomatic, it was repaired surgically.
- The aneurysm-related mortality was 53% lower in the screening group.
- However, despite the relative risk reduction in the MASS trial, there were 65 AAA-related deaths in the intervention group (absolute risk of 0.19%), and 113 AAA-related deaths in the control group (absolute risk 0.33%).
Screening
Cost-Effectiveness
It is estimated that abdominal aortic aneurysm screening is as cost-effective as mammography for breast cancer detection as well as therapeutic interventions such as coronary artery bypass graft surgery with a cost of $11,285 per quality adjusted life year saved.[5]
Safety
- Physical examinations may detect large AAAs, but is not specific or sensitive enough to detect smaller ones.[6]
- The cornerstone of AAA screening is ultrasonography. It is available in almost every medical center and many physician offices.
- Abdominal aortic ultrasonography is fast, inexpensive, safe and well-tolerated by most patients
- It is highly accurate with 95% sensitivity and 100% specificity for AAAs.[7]
- The most important limitations of ultrasonography are:
- Computed tomography (CT) and magnetic resonance angiography are accurate for diagnosing AAA, but are less often used as a first-degree screening modality because of the lack of availability, and the risks and side-effects of iodinated contrasts for CT.
Ethics
- Screening using ultrasonography causes no serious side effects, and is therefore ethically acceptable.[8]
- Several studies have shown that screening for AAAs and diagnosing asymptomatic small aneurysms in clinical practice were not associated with long-term emotional or psychological stress to patients.[9]
- A simple screening ultrasound test costs approximately $500, for which Medicare usually reimburses $160.
- Lack of insurance coverage raises the ethical dilemma of AAA screening being available only to the elite who can afford it.
Identification as a Trigger to Screen for Polyvascular Disease
- Small, asymptomatic AAAs (3-5.5 cm) may serve as a marker for vascular disease elsewhere, thus finding one provides good reason to aggressively start to modify risk factors.
Follow-Up Intervals
- Periodic ultrasonographic surveillance is recommended for aneurysms smaller than the repair cutoff.
- If an abdominal aortic aneurysm is 4 to 5.4 cm then surveillance ultrasounds can be obtained every 6 to 12 months.
- If an abdominal aortic aneurysm is 3 to 4 cm then surveillance ultrasounds can be obtained every 2 to 3 years.
- However, definite and unified parameters for appropriate surveillance intervals have not yet been determined because clinical trials have enrolled heterogeneous populations and used different standards for diagnosis and management.
- In general, older men may need more frequent follow-up scans, as men older than 70 years have three times the rate of progression than younger men.
- Aneurysm diameters determined by ultrasound may vary up to 0.5 cm, which should be considered when recommending optimal times for rescanning and repair.
Recommendations by The United States Preventive Service Task Force
Clinical practice guidelines[10] and systematic review[11] by the United States Preventive Service Task Force in 2014 stated:
- "The USPSTF recommends 1-time screening screening for AAA with ultrasonography in men aged 65 to 75 years who have ever smoked."
- "The USPSTF recommends that clinicians selectively offer screening for AAA in men aged 65 to 75 years who have never smoked"
- "The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for AAA in women aged 65 to 75 years who have ever smoked"
- "The USPSTF recommends against routine screening for AAA in women who have never smoked."
The projected benefit of screening is:[12]
- Number needed to invite to prevent one death is 175 - 225.
Management of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations) : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Screening High-Risk Populations[13]
| Class I |
| "1.Men 60 years of age or older who are either the siblings or offspring of patients with AAAs should undergo physical examination and ultrasound screening for detection of aortic aneurysms. (Level of Evidence: B)" |
| Class IIa |
| "1.Men who are 65 to 75 years of age who have ever smoked should undergo a physical examination and 1-time ultrasound screening for detection of AAAs. (Level of Evidence: B)" |
Sources
http://www.uspreventiveservicestaskforce.org/uspstf/uspsaneu.htm
References
- ↑ Gillum RF (1995). "Epidemiology of aortic aneurysm in the United States". Journal of Clinical Epidemiology. 48 (11): 1289–98. PMID 7490591. Retrieved 2012-10-27. Unknown parameter
|month=ignored (help) - ↑ 2.0 2.1 "Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial". BMJ (Clinical Research Ed.). 325 (7373): 1135. 2002. PMC 133450. PMID 12433761. Retrieved 2012-10-27. Unknown parameter
|month=ignored (help) - ↑ 3.0 3.1 Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, Thompson SG, Walker NM (2002). "The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial". Lancet. 360 (9345): 1531–9. PMID 12443589. Retrieved 2012-10-27. Unknown parameter
|month=ignored (help) - ↑ Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PW, Houston-Miller N (2003). "34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap?". Journal of the American College of Cardiology. 41 (11): 1863–74. PMID 12798553. Retrieved 2012-10-27. Unknown parameter
|month=ignored (help) - ↑ Kent KC, Zwolak RM, Jaff MR, Hollenbeck ST, Thompson RW, Schermerhorn ML, Sicard GA, Riles TS, Cronenwett JL (2004). "Screening for abdominal aortic aneurysm: a consensus statement". Journal of Vascular Surgery. 39 (1): 267–9. doi:10.1016/j.jvs.2003.08.019. PMID 14718853. Retrieved 2012-10-27. Unknown parameter
|month=ignored (help) - ↑ Fink, Howard A.; Lederle, Frank A.; Roth, Craig S.; Bowles, Carolyn A.; Nelson, David B.; Haas, Michele A. (2000). "The Accuracy of Physical Examination to Detect Abdominal Aortic Aneurysm". Archives of Internal Medicine. 160 (6): 833. doi:10.1001/archinte.160.6.833. ISSN 0003-9926.
- ↑ Rubano, Elizabeth; Mehta, Ninfa; Caputo, William; Paladino, Lorenzo; Sinert, Richard; Carpenter, Christopher (2013). "Systematic Review: Emergency Department Bedside Ultrasonography for Diagnosing Suspected Abdominal Aortic Aneurysm". Academic Emergency Medicine. 20 (2): 128–138. doi:10.1111/acem.12080. ISSN 1069-6563.
- ↑ Haar, Gail ter (2011). "Ultrasonic imaging: safety considerations". Interface Focus. 1 (4): 686–697. doi:10.1098/rsfs.2011.0029. ISSN 2042-8898.
- ↑ Vammen S, Lindholt JS, Ostergaard L, Fasting H, Henneberg EW (2001). "Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion". The British Journal of Surgery. 88 (8): 1066–72. doi:10.1046/j.0007-1323.2001.01845.x. PMID 11488791. Retrieved 2012-10-27. Unknown parameter
|month=ignored (help) - ↑ LeFevre ML (2014). "Screening for Abdominal Aortic Aneurysm: U.S. Preventive Services Task Force Recommendation Statement". Ann Intern Med. doi:10.7326/M14-1204. PMID 24957320.
- ↑ Guirguis-Blake JM, Beil TL, Senger CA, Whitlock EP (2014). "Ultrasonography screening for abdominal aortic aneurysms: a systematic evidence review for the U.S. Preventive Services Task Force". Ann Intern Med. 160 (5): 321–9. doi:10.7326/M13-1844. PMID 24473919. Review in: Ann Intern Med. 2014 May 20;160(10):JC6
- ↑ Burden AC (2014). "ACP Journal Club. Review: ultrasonography screening reduces long-term abdominal aortic aneurysm-related mortality". Ann Intern Med. 160 (10): JC6. doi:10.7326/0003-4819-160-10-201405200-02006. PMID 24842440.
- ↑ Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss L; et al. (2013). "Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". J Am Coll Cardiol. 61 (14): 1555–70. doi:10.1016/j.jacc.2013.01.004. PMC 4492473. PMID 23473760.